[Rational therapy with erythrocyte concentrates - Update 2022]

Area of Science:

• Transfusion Medicine
• Hematology
• Medical Guidelines

Background:

• Effective use of red blood cell concentrates requires clear indications.
• Previous guidelines were published in 2009 and partially revised in 2014.
• Ensuring rational therapy with blood components is a key clinical objective.

Purpose of the Study:

• To present the systematically revised 2020 guidelines for therapy with blood components and plasma derivatives.
• To provide updated recommendations for the rational use of red blood cell concentrates.
• To inform healthcare professionals about the latest evidence-based practices in transfusion medicine.

Main Methods:

• Systematic revision of existing guidelines.
• Incorporation of the latest scientific evidence and clinical practice.
• Review and update of recommendations by the German Medical Association.

Main Results:

• The article presents the comprehensively revised "Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives" from 2020.
• Updated recommendations ensure a rational basis for prescribing red blood cell concentrates.
• The revised guidelines reflect current standards in transfusion medicine.

Conclusions:

• Adherence to the revised guidelines promotes the judicious use of red blood cell concentrates.
• The updated guidelines serve as a critical resource for optimizing patient care in transfusion medicine.
• Regular revision of clinical guidelines is essential for maintaining high standards of medical practice.